Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01649167|
Recruitment Status : Completed
First Posted : July 25, 2012
Last Update Posted : July 25, 2012
Background: Obesity in pregnancy is increasing and is a risk factor for metabolic pathology such as preeclampsia. Leptin is an adipokine which has a direct relationship to obesity.
Aim: to measure leptin in lean, obese and diabetic pregnant women at three months intervals throughout their pregnancies.
Methods: Pregnant women were recruited in the 1st trimester of pregnancy, and three groups were formed: a) with pregestational Body Mass Index (BMI) less than 25 kg/m2, b) BMI higher than 25 kg/m2 and c) with Gestational Diabetes Mellitus (GDM). Serum levels of leptin were measured with radioimmunoassay (RIA) technique.
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||55 participants|
|Official Title:||Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia|
|Study Start Date :||February 2009|
|Actual Study Completion Date :||November 2010|
Pregnant women with overweight/obesity
Pregnant women with gestational diabetes
Pregnant women with normal weight
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01649167
|Principal Investigator:||Verónica Jackeline García Solorio, MSc||Autonomous University of the State of Mexico|
|Study Chair:||Hugo Mendieta Zerón, PhD||Autonomous University of the State of Mexico|